NRG-GI008: This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

Objective

Clinical Trial Summary

Principal Investigator(s)

Heidi McKean, MD

Clinical Trial Categories

• Colorectal Cancer

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org